AVCT Stock Price, Chart, Stats & News

Avacta Group Plc
Save
Avacta Group Plc (AVCT) does not currently pay a dividend.
324.14M
Market cap
–
Current P/E
113.64x
Forward P/E
AVCT chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Avacta Group Plc operates as a clinical-stage biopharmaceutical company, specializing in the development of cancer therapies and diagnostic solutions. These advancements are driven by its proprietary Affimer and pre CISION technology platforms, with the company's activities spanning the United Kingdom, North America, South Korea, and broader regions of Asia and Europe.
Similar securities
Based on sector and market capitalization
Report issue





